News | Bain Capital Life Sciences

Bain Capital

Scroll up to People

News

PRESS RELEASES April 2, 2025

Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs

PRESS RELEASES July 28, 2025

Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients

IN THE NEWS April 2, 2025

Atsena gets Bain's support in $150M Series C to thwart blindness with gene therapy

Published in Endpoints News

IN THE NEWS April 2, 2025

Gene therapy firm secures $150M round led by Bain Capital

Published in Triangle Business Journal

IN THE NEWS February 7, 2025

Bain Capital buys 340-year-old pharma company to fast-track Japan’s drug development

Published in Financial Times

PORTFOLIO NEWS January 27, 2025

Kailera Therapeutics Appoints Jamie Coleman as Chief Commercial Officer

PORTFOLIO NEWS January 13, 2025

X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand

PORTFOLIO NEWS January 8, 2025

Kailera Therapeutics Appoints Laurie Stelzer as Chief Financial Officer

PORTFOLIO NEWS January 7, 2025

Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer

See all Life Sciences news

Scroll down to Contact